Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/01/2010 | WO2010027497A3 Preparations, compositions, and methods for nucleic acid sequencing |
07/01/2010 | WO2010025420A3 Methods of identifying functional characteristics of promoters, transcription modifying proteins and transcription modulating agents |
07/01/2010 | WO2010023605A3 Method for the identification of genes involved in neurodegenerative processes |
07/01/2010 | WO2010022145A3 Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function |
07/01/2010 | WO2010014857A3 Chromosome therapy |
07/01/2010 | WO2010002160A3 Gene of porcine alpha-s1 casein, a promoter of the same and use thereof |
07/01/2010 | WO2009152529A3 Programming and reprogramming of cells |
07/01/2010 | WO2009065618A8 Improvement of transfection results of non-viral gene delivery systems by influencing the congenital immune system |
07/01/2010 | WO2009051801A3 Chemical inhibitors of inhibitors of differentiation |
07/01/2010 | US20100170014 Heat- and ethylene-inducible fruit specific promoter |
07/01/2010 | US20100170011 Plants having enhanced yield-related traits and a method for making the same |
07/01/2010 | US20100170010 Use of genes encoding membrane transporter pumps to stimulate the production of secondary metabolites in biological cells |
07/01/2010 | US20100170009 Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof |
07/01/2010 | US20100170007 Genes controlling winter dormancy in perennials and uses thereof |
07/01/2010 | US20100170006 Methods for screening of novel functions of receptor like kinases |
07/01/2010 | US20100170005 Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants |
07/01/2010 | US20100170004 Compositions and methods for the modification of gene expression |
07/01/2010 | US20100170002 Promoter, promoter control elements, and combinations, and uses thereof |
07/01/2010 | US20100170001 Method for Providing Cucumber Fruits with an Extended Shelf Life |
07/01/2010 | US20100170000 Rna constructs |
07/01/2010 | US20100169999 Induced chromosome doubling in plants |
07/01/2010 | US20100169997 Generating transgenic plant comprising wuschel (WUS) transcription factor for use as tool in ennhancing shoot and floral meristem integrity; producing an apomictic plant line or haploid plants |
07/01/2010 | US20100169995 Targeted gene disruptions in the iqgap2 gene |
07/01/2010 | US20100169992 Fgfr4 antibodies |
07/01/2010 | US20100169991 Biopesticide comprising insect belonging to family coccinellidae |
07/01/2010 | US20100169986 Conditional Mst Overexpressing Construct and Conditional Myostatin Overexpressing Transgenic Mouse |
07/01/2010 | US20100168455 Production of Hydroxylated Fatty Acids in Genetically Modified Plants |
07/01/2010 | US20100168408 Compositions and methods for labeling of nucleic acid molecules |
07/01/2010 | US20100168389 Process for producing extract for cell-free protein synthesis and cell extract produced thereby |
07/01/2010 | US20100168387 Chimeric CrylE Delta Endotoxin and Methods of Controlling Insects |
07/01/2010 | US20100168386 Fusion protein carrying neurotrophin across the blood-brain barrier, encoding gene and uses thereof |
07/01/2010 | US20100168381 Conjugates of membrane translocating agents and pharmaceutically active agents |
07/01/2010 | US20100168215 Methods and compositions for the treatment of neurological disease |
07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
07/01/2010 | US20100168213 Protein-coding RNA to correct mitochondrial dysfunction |
07/01/2010 | US20100168212 Oligomers |
07/01/2010 | US20100168209 Apoptosis inducer for cancer cell |
07/01/2010 | US20100168208 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
07/01/2010 | US20100168207 Compositions and methods for sirna inhibition of angiogenesis |
07/01/2010 | US20100168206 GNAQ Targeted dsRNA Compositions And Methods For Inhibiting Expression |
07/01/2010 | US20100168057 Fungal growth inhibitor |
07/01/2010 | US20100168047 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |
07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
07/01/2010 | US20100168026 Insulin secretion inducer, and accelerator for increasing the number of pancreatic beta-cells |
07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
07/01/2010 | US20100168020 Stabilized receptor polypeptides and uses thereof |
07/01/2010 | US20100168015 Peptides with capacity for binding with interleukine 10 (il-10) |
07/01/2010 | US20100168014 Screening method |
07/01/2010 | US20100168006 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
07/01/2010 | US20100167987 Methods and pharmaceutical compositions for healing wounds |
07/01/2010 | US20100167411 Novel slc17-type transporter protein in mammal and use thereof |
07/01/2010 | US20100167405 Processes for improved strain engineering |
07/01/2010 | US20100167404 Methods of Reprogramming Animal Somatic Cells |
07/01/2010 | US20100167395 Humanized GM-CSF antibodies |
07/01/2010 | US20100167394 Ultramarine fluorescent protein |
07/01/2010 | US20100167393 Modified human thymic stromal lymphopoietin |
07/01/2010 | US20100167392 Factor viii compositions and methods |
07/01/2010 | US20100167389 Synthetic expression vectors for insect cells |
07/01/2010 | US20100167379 Bacteria for high efficiency cloning |
07/01/2010 | US20100167377 Recombinant viruses comprising the membrane-proximal domain of VSV G protein |
07/01/2010 | US20100167375 Novel Lipolytic Enzyme LIP2 |
07/01/2010 | US20100167363 Yeast with increased butanol tolerance involving filamentous growth response |
07/01/2010 | US20100167362 Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol B |
07/01/2010 | US20100167358 Compositions and processes for improved plasmid dna production |
07/01/2010 | US20100167357 Obligate heterodimer meganucleases and uses thereof |
07/01/2010 | US20100167356 Homologous recombination-based DNA cloning methods and compositions |
07/01/2010 | US20100167354 Methods and compositions for amplification of rna sequences |
07/01/2010 | US20100167352 Infectious clones |
07/01/2010 | US20100167349 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
07/01/2010 | US20100167348 Peptide capable of binding to immunoglobulin |
07/01/2010 | US20100167347 used to incorporate a selected amino acid in a specific position in a growing polypeptide chain (during nucleic acid translation) in response to a selector codon that is recognized by the tRNA |
07/01/2010 | US20100167345 Halohydrin dehalogenases and related polynucleotides |
07/01/2010 | US20100167344 Novel sialidases |
07/01/2010 | US20100167343 Oviduct specific expression promoter and recombinant expression vector comprising the same |
07/01/2010 | US20100167341 Novel protein expression system |
07/01/2010 | US20100167304 Variable valve apparatus and methods |
07/01/2010 | US20100167298 PURO-DHFR Quadrifunctional Marker and its use in Protein Production |
07/01/2010 | US20100167292 High fidelity polymerases and uses thereof |
07/01/2010 | US20100167287 Crude biological derivatives competent for nucleic acid detection |
07/01/2010 | US20100167275 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels |
07/01/2010 | US20100167040 Identification of a novel type of sucrose synthase and use thereof in fiber modification |
07/01/2010 | US20100166799 Adenoviral vectors and methods and uses related thereto |
07/01/2010 | US20100166797 Gammaretrovirus associated with cancer |
07/01/2010 | US20100166793 Protease-resistant modified seb and vaccine containing the same |
07/01/2010 | US20100166792 Antigenic Polypeptides |
07/01/2010 | US20100166791 Circovirus sequences associated with piglet weight loss disease (pwd) |
07/01/2010 | US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof |
07/01/2010 | US20100166784 Method and compositions for modulating th17 cell development |
07/01/2010 | US20100166780 CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity |
07/01/2010 | US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx |
07/01/2010 | US20100166770 Antagonists of bacterial sequences |
07/01/2010 | US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles |
07/01/2010 | US20100166768 High Affinity Human Antibodies to PCSK9 |
07/01/2010 | US20100166767 Engineered anti-il-23r antibodies |
07/01/2010 | US20100166766 Engineered anti-tslp antibody |
07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
07/01/2010 | US20100166758 Novel antibody molecules and nucleic acids |
07/01/2010 | US20100166755 Anti-egfr antibodies |
07/01/2010 | US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
07/01/2010 | US20100166749 Polypeptide variants with altered effector function |